$1.06
-0.06[-5.36%]
Last update: 10:04AM Get Real Time Here
bluebird bio
(NASDAQ:BLUE)bluebird bio Stock (NASDAQ:BLUE), Quotes and News Summary
bluebird bio Stock (NASDAQ: BLUE) stock price, news, charts, stock research, profile.
| Open | $1.140 |
| Close | - |
| Volume / Avg. | 2.026M / 8.280M |
| Day Range | 1.030 - 1.160 |
| 52 Wk Range | 0.851 - 5.530 |
| Market Cap | $204.306M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 51 |
| Short Interest | 18.07% |
| Days to Cover | 7.71 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy bluebird bio (BLUE) stock?
You can purchase shares of bluebird bio (NASDAQ: BLUE) through any online brokerage.
Who are bluebird bio's (BLUE) competitors?
Other companies in bluebird bio’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Innate Pharma (NASDAQ:IPHA), Galectin Therapeutics (NASDAQ:GALT), Adverum Biotechnologies (NASDAQ:ADVM) and Atossa Therapeutics (NASDAQ:ATOS).
What is the target price for bluebird bio (BLUE) stock?
The latest price target for bluebird bio (NASDAQ: BLUE) was reported by RBC Capital on Wednesday, March 27, 2024. The analyst firm set a price target for 6.00 expecting BLUE to rise to within 12 months (a possible 466.04% upside). 15 analyst firms have reported ratings in the last year.
Current Stock Price for bluebird bio (BLUE)?
The stock price for bluebird bio (NASDAQ: BLUE) is $1.06 last updated Today at May 10, 2024 at 10:04 AM EDT.
Does bluebird bio (BLUE) pay a dividend?
There are no upcoming dividends for bluebird bio.
When is bluebird bio (NASDAQ:BLUE) reporting earnings?
bluebird bio’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
Is bluebird bio (BLUE) going to split?
There is no upcoming split for bluebird bio.
What sector and industry does bluebird bio (BLUE) operate in?
bluebird bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.